申请人:LEXICON PHARMACEUTICALS, INC.
公开号:US10106569B2
公开(公告)日:2018-10-23
Inhibitors of sodium glucose cotransporter 1 (SGLT1), compositions comprising them, and methods of their use to treat diseases and disorders such as diabetes are disclosed. Particular compounds are of the formula:
the various substituents of which are defined herein.
本发明公开了钠葡萄糖共转运体 1 (SGLT1) 的抑制剂、包含这些抑制剂的组合物以及使用这些抑制剂治疗糖尿病等疾病的方法。特定化合物的化学式如下
其中的各种取代基在本文中定义。